Fundz

Mira1a Therapeutics reported raising $6.51 Million in an initial SEC Form D filing, from an offering of $6.51 Million

PUBLIC · MIRAAug 01, 2022Late filing, first sale Nov 9, 2021

Amount Raised

$6.51 Million

$6.51 Million sold, per SEC Form D (first sale Nov 9, 2021)

Round Type

Venture

BaltimoreBiotechnologyHealthcareTherapeuticsPharmaceuticalBiopharma

Who to call at Mira1a Therapeutics, and when

A new round usually means Mira1a Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Mira1a Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Mira1a Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Mira1a Therapeutics. With Fundz connected, it knows.

See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Mira1a Therapeutics

Location

855 N WOLFE STREET #601

Baltimore, Maryland, United States

About

MIRA1a is being developed as the first prescription drug to target the CB1 and CB2 receptors for chronic pain and anxiety without the impurities of marijuana or its side effects such as increased appetite and paranoia.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Mira1a Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Mira1a Therapeutics's next move

See what Strategic adds

Mira1a Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.